[Trends in parathyroid hormone plasma concentration in critically ill patients: prospective observational study].


Journal

Wiadomosci lekarskie (Warsaw, Poland : 1960)
ISSN: 0043-5147
Titre abrégé: Wiad Lek
Pays: Poland
ID NLM: 9705467

Informations de publication

Date de publication:
Historique:
entrez: 24 2 2019
pubmed: 24 2 2019
medline: 9 8 2019
Statut: ppublish

Résumé

Introduction: There is no data in the literature regarding trends in parathormone serum concentration assessment in critically ill patients. The aim: To assess the parathyroid hormone plasma concentrations and kinetics in critically ill patients admitted to the intensive care unit due to multiorgan failure. Materials and methods: Thirty multiorgan failure (at least circulatory and respiratory failure) patients were included. Patients who met any of the following criteria were excluded: acute liver failure, end stage renal disease, hypercalcemia, parathyroid gland disease, severe vitamin D deficiency, admission from another ICU or readmission, age younger than 18 years, or lack of consent from relatives. We performed the parathyroid hormone plasma measurements in 12-hour time intervals. Results: The initial parathyroid hormone plasma concentration levels in the study group were rather variable and medians exceeded laboratory reference values. Especially in the acute kidney injury subpopulation treated with continuous renal replacement therapy these trends were emphasized. The initial parathyroid hormone plasma concentration levels in this group significantly exceeded laboratory reference values in 80% of patients. After initial spike we observed subsequent drop between second and third measurement. The distribution of plasma levels was rather variable between second and third measurement in this group of patients. Conclusions: The parathyroid hormone plasma concentration levels in the critically ill patients are variable. In the acute kidney injury subpopulation treated with continuous renal replacement therapy after initial significant spike we observed subsequent drop between second and third measurement.

Identifiants

pubmed: 30796860

Substances chimiques

Parathyroid Hormone 0

Types de publication

Journal Article Observational Study

Langues

pol

Pagination

40-46

Auteurs

Aneta Czarnik (A)

Oddział Endokrynologii, Szpital Wojewódzki w Opolu, Opole, Polska.

Tomasz Czarnik (T)

Oddział Anestezjologii i Intensywnej Terapii, Uniwersytecki Szpital Kliniczny w Opolu, Opole, Polska.

Robert Kapłon (R)

Wydział Informatyki i Zarządzania, Politechnika Wrocławska, Wrocław, Polska.

Marek Bolanowski (M)

Katedra i Klinika Endokrynologii, Diabetologii i Leczenia Izotopami, Uniwersytet Medyczny we Wrocławiu, Wrocław, Polska.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH